Advertisement
Australia markets closed

  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     

  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     

  • AUD/USD

    0.6535
    +0.0012 (+0.18%)
     

  • OIL

    83.89
    +0.32 (+0.38%)
     

  • GOLD

    2,360.30
    +17.80 (+0.76%)
     

  • Bitcoin AUD

    98,574.32
    +1,256.97 (+1.29%)
     

  • CMC Crypto 200

    1,392.89
    -3.64 (-0.26%)
     

  • AUD/EUR

    0.6087
    +0.0014 (+0.22%)
     

  • AUD/NZD

    1.0977
    +0.0020 (+0.18%)
     

  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     

  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     

  • FTSE

    8,111.58
    +32.72 (+0.41%)
     

  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     

  • DAX

    18,049.88
    +132.60 (+0.74%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Entasis Therapeutics (ETTX) Jumps: Stock Rises 5.4%

Zacks Equity Research
·2-min read

Entasis Therapeutics Holdings Inc. ETTX was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $2.54 –$3.32 in the past one-month time frame, witnessed a sharp increase on Friday.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Entasis Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Entasis Therapeutics Holdings Inc. Price

Entasis Therapeutics Holdings Inc. Price
Entasis Therapeutics Holdings Inc. Price

Entasis Therapeutics Holdings Inc. price | Entasis Therapeutics Holdings Inc. Quote

ADVERTISEMENT

A better-ranked stock in the Medical – Drugs industry is Pacira BioSciences Inc PCRX, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.

This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.

See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Pacira BioSciences, Inc. (PCRX) : Free Stock Analysis Report
 
Entasis Therapeutics Holdings Inc. (ETTX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research